Anti-HIV NCP7 Intrabody [+36GFP] (IAB-B013(G))
Recombinant anti-HIV NCP7 intrabody in fusion with +36GFP works within cells to bind HIV NCP7, expressed in E. coli cells.
Specifications
- Immunogen
- human immunodeficiency virus nucleocapsid protein, NCp7
- Host
- human
- Type
- scFv-(+36GFP)
- Cell Penetrating Peptide
- +36 GFP
GFP with a theoretical net charge of +36 (+36 GFP) penetrated several different mammalian cell lines at very low (nanomolar) concentrations. Cationic peptides and proteins have been observed to penetrate cells, and both natural and synthetic cell-penetrating peptides are widely used as delivery vehicles. However, whereas a covalent link between the cell-penetrating peptide and its cargo is typically required.
- Species Reactivity
- HIV
- Applications
- Can be useful in applications such as: Coimmunopricipation; Functional studies
Target
- Alternative Names
- HIV NCP7; human immunodeficiency virus nucleocapsid protein 7
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: